TargetMol

Dibekacin sulfate

Product Code:
 
TAR-T21036
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T21036-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21036-50mg50mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21036-5mg5mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Dibekacin sulfate, an analog of KANAMYCIN, has antitubercular as well as broad-spectrum antimicrobial properties.
CAS:
58580-55-5
Formula:
C18H37N5O12S
Molecular Weight:
547.58
Purity:
0.98
SMILES:
[O-]S([O-])(=O)=O.NC[C@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@@H]3O)[C@H]2O)O1

References

1. Zhang S, Chen T, Jia J, Guo L, Zhang H, Li C, Qiao R. Establishment of a highly efficient conjugation protocol for Streptomyces kanamyceticus ATCC12853. Microbiologyopen. 2018 Nov 17:e747. doi: 10.1002/mbo3.747. [Epub ahead of print] PubMed PMID: 30449069. 2. Liu L, Li Z, Liu X, Guo S, Guo L, Liu X. Bacterial distribution, changes of drug susceptibility and clinical characteristics in patients with diabetic foot infection. Exp Ther Med. 2018 Oct;16(4):3094-3098. doi: 10.3892/etm.2018.6530. Epub 2018 Jul 26. PubMed PMID: 30214532; PubMed Central PMCID: PMC6125979. 3. Ohtsuru T, Morita Y, Murata Y, Munakata Y, Itoh M, Kato Y, Okazaki K. Custom-made, antibiotic-loaded, acrylic cement spacers using a dental silicone template for treatment of infected hip prostheses. Eur J Orthop Surg Traumatol. 2018 May;28(4):615-620. doi: 10.1007/s00590-017-2117-3. Epub 2018 Jan 13. PubMed PMID: 29332203. 4. Uechi K, Tada T, Shimada K, Nakasone I, Sonozaki T, Kirikae T, Fujita J. Emergence of ArmA, a 16S rRNA methylase in highly aminoglycoside-resistant clinical isolates of Klebsiella pneumoniae and Klebsiella oxytoca in Okinawa, Japan. J Infect Chemother. 2018 Jan;24(1):68-70. doi: 10.1016/j.jiac.2017.09.006. Epub 2017 Oct 21. PubMed PMID: 29066218.